Momenta Pharmaceuticals, Inc. News Headlines

MNTA 
$19
*  
1.43
8.14%
Get MNTA Alerts
*Delayed - data as of Apr. 20, 2015  -  Find a broker to begin trading MNTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Teva Proves You Cannot Escape The Patent Cliff
9/4/2014 9:47:00 AM - Seeking Alpha




Momenta Pharmaceuticals Heading For A Repeat
8/5/2014 8:15:00 AM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha












Momenta Pharmaceuticals Has Value In The Sum Of The Drugs
4/29/2014 10:35:00 AM - Seeking Alpha






Sector Update: Healthcare
4/21/2014 1:05:58 PM - MT Newswires












Can Teva Survive Its Cash Cow Loss?
10/23/2013 3:05:00 PM - Seeking Alpha






2014 Isn't Looking To Good For Eli Lilly And Company
9/30/2013 3:34:00 PM - Seeking Alpha


TEVA Should Embrace Copaxone Patent Expiration
9/3/2013 4:26:00 PM - Seeking Alpha